πŸ‡ΊπŸ‡Έ FDA
Patent

US 6172090

Pharmaceutical composition

expired A61KA61K31/135A61K31/19

Quick answer

US patent 6172090 (Pharmaceutical composition) held by Takeda Chemical Industries Ltd. expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Takeda Chemical Industries Ltd.
Grant date
Tue Jan 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/135, A61K31/19, A61K31/415, A61K31/42